President Donald Trump on Thursday nominated Dr. Nicole B. Saphier, a radiologist and breast-imaging specialist at Memorial Sloan Kettering Cancer Center Monmouth, to serve as the next U.S. surgeon general, moving within minutes to fill the post after pulling the stalled nomination of Dr. Casey Means.
The announcement came less than half an hour after Trump posted on Truth Social that Means, the preferred pick of Health and Human Services Secretary Robert F. Kennedy Jr., would be withdrawn. Means had failed to secure enough votes to advance out of the Senate Committee on Health, Education, Labor, and Pensions, making her the second consecutive nominee to fall short. Dr. Janette Nesheiwat was Trump's first choice before Means replaced her last May.
Three nominees for one job. That alone tells you something about the political fight over who shapes the nation's public-health messaging, and who in the Senate has been willing to stand in the way.
Trump left no ambiguity about whom he held responsible. In a Truth Social post announcing the change, the president blamed Sen. Bill Cassidy, the Louisiana Republican who chairs the HELP committee, for the collapse of Means' nomination.
Trump wrote on Truth Social:
"For months, Senator Bill Cassidy... has stood in the way of Robert F. Kennedy Jr.'s Nominee, Casey Means, for the important position of U.S. Surgeon General."
He called Cassidy a "very disloyal person" and cited the senator's vote to impeach him. The president also pointed to what he described as Cassidy's "intransigence and political games" as the reason Means could not move forward.
Means' confirmation hearing with the HELP committee was originally postponed in late 2025. When it was eventually held earlier this year, she did not gather enough votes. AP News reported that concerns about her qualifications and vaccine views drove much of the opposition.
The pattern of Senate holdouts blocking Trump nominees is not new. A similar standoff played out over the Kevin Warsh Fed nomination, where one senator's resistance stalled a key appointment until a deal was struck.
Trump thanked Means for her service and said she would continue to promote the Make America Healthy Again agenda outside the surgeon general's office. In a separate post, he wrote:
"Casey will continue to fight for MAHA on the many important health issues facing our country, such as the rising childhood disease epidemic, increased autism rates, poor nutrition, over-medicalization, and researching the root causes of infertility, and many other difficult medical problems."
Saphier, 44, serves as director of breast imaging at Memorial Sloan Kettering Cancer Center Monmouth. She is also the host of the "Wellness Unmasked" podcast. Trump called her a "star physician" who has guided women through breast cancer and advocated for early cancer detection and prevention.
Fox News reported that Saphier was previously a contributor to the network. Trump praised her communication skills in his announcement post:
"She is also an INCREDIBLE COMMUNICATOR, who makes complicated health issues more easily understood by all Americans."
Saphier is not a stranger to public-health fights. In 2022, she claimed the CDC would mandate coronavirus vaccines for schoolchildren. In 2025, she asked both the CDC and the American Academy of Pediatrics to allow parents to delay the MMR vaccine for their children. As she put it, parents should be able to "have that conversation and let them wait until their child's a little bit older."
That willingness to push back against public-health orthodoxy aligns her with the broader MAHA movement, though the Washington Examiner noted that Saphier is viewed as a more conventional physician choice than Means. Cassidy and other senators had raised concerns about Means' wellness views and vaccine skepticism, objections that Saphier's traditional medical credentials may help neutralize.
Saphier supports parts of the MAHA agenda, including reducing food additives and ultraprocessed foods. But she has been more openly pro-vaccine than Kennedy, a distinction that could smooth her path through the Senate.
She has also shown a willingness to criticize the administration's own health messaging when she believes it falls short. On her podcast, Saphier said of one government report:
"There were a lot of flaws in this report. In fact, it was pretty embarrassing."
She went further in another episode, saying:
"When we keep hearing radical transparency and we're going to regain trust, I can tell you these shenanigans are taking us farther away from that mission."
Those comments suggest Saphier is not a rubber stamp. Whether that independence helps or hurts her in a confirmation fight remains to be seen. National Review noted that she became the third nominee for the post after both Nesheiwat and Means failed to win enough Senate support, a track record that raises the stakes for this pick considerably.
The broader MAHA coalition itself has faced tensions beyond the surgeon general fight. A recent Supreme Court case over Monsanto's Roundup exposed fault lines between MAHA allies and the administration over federal regulatory authority.
Saphier's nomination now heads to the same Senate committee that blocked Means. Cassidy still chairs it. The White House did not respond to the Daily Caller's request for comment on the new pick.
Just The News reported that Trump framed Saphier as a strong communicator aligned with his health agenda, language that mirrors the way he originally described Means, whom he once credited with "impeccable 'MAHA' credentials."
The question now is whether Saphier's medical résumé and mainstream credentials can clear the hurdle that two previous nominees could not. She has the cancer-research bona fides, the public-health track record, and the media fluency. What she does not yet have is a confirmed vote count.
The administration has shown it can move quickly when nominees stall, a pattern visible across agencies and branches, including Trump's stated readiness to fill a Supreme Court vacancy should one arise.
Three nominees in roughly a year for one post. At some point, the Senate has to decide whether it wants a surgeon general or just another fight.
